RxDoctor Payments DataLook up a doctor →

Veozah: payments to doctors

Payments that named Veozah as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$12.3M
Providers
68,399
Transactions
248,059
Average per transaction
$50

The per-transaction average — $50 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 68,399 providers the average total is $180, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Astellas Pharma US Inc$11,937,85497.1%
Astellas Pharma Global Development$249,2552.0%
Astellas Pharma Europe Ltd$100,6140.8%
Astellas US LLC$7,2000.1%
← All drugs & devices